Andrew Elmendorf works with Jonathan Flak, PhD, to study diabetes, while he also pursues his PhD at the Indiana University (IU) School of Medicine in the department of pharmacology and toxicology.
Prior to joining the IBRI, Elmendorf was a research technician at the IU School of Medicine, where he was involved in prostate cancer research, as well as researching the cellular response to stress in health and disease. During his undergraduate years, he was involved in medical research investigating molecular mechanisms by which bone tissue senses mechanical loading, also at the IU School of Medicine.
View Elmendorf's published research here.